U.S. IPO Week Ahead: Year's Largest U.S. Tech Company To IPO, Nutanix, Leads 5-Deal Week

Five IPOs are scheduled to close out the third quarter, putting September on pace to be the year's most active month for IPOs. Nutanix's highly-anticipated IPO will get the most attention, given its growth, scale, and implications for the massive backlog of Silicon Valley tech IPOs with private valuations of more than $1 billion. The other three notable IPOs this week offer various growth plays in the health care space, including a medical REIT, genetic test company and a provider of health support services.

Renaissance Capital's IPO Calendar - Week of 9/26/2016
Issuer Business	Symbol Exchange	Deal Size $mil	Price Range Shares Filed	Lead Managers
MedEquities Realty Trust Nashville, TN	MRT NYSE	$259	$12 - $14 19,925,333	FBR Capital Markets J.P. Morgan
Recently-formed REIT focused on health care properties in Texas and California.
Nutanix San Jose, CA	NTNX Nasdaq	$168	$11 - $13 14,000,000	Goldman Sachs Morgan Stanley
Leading provider of hyperconverged IT infrastructure software and appliances.
Tabula Rasa HealthCare Moorestown, NJ	TRHC Nasdaq	$60	$13 - $15 4,300,000	Wells Fargo Securities UBS Investment Bank
Provides risk management solutions to reduce adverse drug events (ADEs) at long-term care facilities.
Fulgent Genetics Temple City, CA	FLGT Nasdaq	$60	$12 - $14 4,600,000	Credit Suisse Piper Jaffray
Offers genetic testing for over 7,500 conditions.
Full Spectrum Sunnyvale, CA	FMAX Nasdaq	$15	$7 - $9 1,875,000	Joseph Gunnar & Co.
Develops and sells products used to create private cellular networks.

Nutanix (Pending:NTNX): On file since December 2015, Nutanix plans to raise $168 million at a $2 billion market cap in its long-awaited IPO. Nutanix is a leader in the rapidly-growing market for "hyperconverged" networking, and it will be the year's second VC-backed tech "unicorn" after Twilio((NYSE:TWLO); +327%). Few IPOs can claim over $200 million in billings in the most recent quarter with 118% growth, though its accumulated deficit of $442 million is just as rare. Recently, IPO investors have been favorable toward high-loss, high-growth stories, and Nutanix has already posted three consecutive quarters of positive cash flow from operations.

MedEquities Realty Trust (NYSE:MRT): The week's largest IPO, MedEquities plans to raise $259 million at a market cap of nearly $400 million. While the REIT is concentrated both by geography (TX and CA are 86% of rent) and customers (top 5 are 97%), it boasts an experienced management team, a portfolio of long-term triple-net leases and a 6.5% annualized yield. Close peerCommunity Healthcare Trust ((NYSE:CHCT); 2015 IPO) is up 25% this year, while Global Medical REIT (OTCQB:GMRE) has traded up 4% from its June 2016 IPO.

Fulgent Genetics (Pending:FLGT): This small but fast-growing genetic test company is set to raise $60 million at a market cap of $235 million. Differentiated with its ability to more than 18,000 gene tests, Fulgent grew sales by 82% in the 2Q, reaching almost $4 million with a 24% operating margin. The seven diagnostics IPOs since 2015 average a return of -37%, though Fulgent's closest peers have outperformed in recent months.

Tabula Rasa HealthCare (Pending:TRHC): Hoping to raise $60 million at a market cap of $251 million, Tabula Rasa helps long-term care facilities avoid adverse drug events from mismanaged prescriptions. The company grew 32% in the first half of 2016, giving it trailing annual sales of $80 million with an adjusted EBITDA margin of 13%.

Full Spectrum (Pending:FMAX): This micro-cap company, which sells products for private cellular networks, pushed back its $15 million IPO to the week ahead. AzurRx BioPharma (Pending:AZRX), a biotech that originally set terms in August, still hopes to raise $12 million

IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. The Renaissance IPO Index is up 2% year-to-date, while the S&P 500 is up 6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Alibaba (NYSE:BABA), Synchrony Financial (NYSE:SYF) and Citizens Financial Group (NYSE:CFG). The Renaissance International IPO Index is flat year-to-date, compared to +5% for ACWX. Renaissance Capital's International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include NN Group and Aena S.A.

By Renaissance Capital IPO Research

Source: http://seekingalpha.com/article/4008199-u-s-ipo-week-ahead-years-largest-u-s-tech-company-ipo-nutanix-leads-5-deal-week